Lyerly HK - Search Results

1

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Gelmann E, Lehrman SN, Blum RM, Barry DW, et al. Yarchoan R, et al. Among authors: lyerly hk. Lancet. 1986 Mar 15;1(8481):575-80. doi: 10.1016/s0140-6736(86)92808-4. Lancet. 1986. PMID: 2869302 Clinical Trial.

2

Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.

Weinhold KJ, Lyerly HK, Matthews TJ, Tyler DS, Ahearne PM, Stine KC, Langlois AJ, Durack DT, Bolognesi DP. Weinhold KJ, et al. Among authors: lyerly hk. Lancet. 1988 Apr 23;1(8591):902-5. doi: 10.1016/s0140-6736(88)91713-8. Lancet. 1988. PMID: 2895830

3

Transmission of HIV by antigen presenting cells during T-cell activation: prevention by 3'-azido-3'-deoxythymidine.

Lyerly HK, Cohen OJ, Weinhold KJ. Lyerly HK, et al. AIDS Res Hum Retroviruses. 1987 Spring;3(1):87-94. doi: 10.1089/aid.1987.3.87. AIDS Res Hum Retroviruses. 1987. PMID: 3497654

4

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.

Lyerly HK, Matthews TJ, Langlois AJ, Bolognesi DP, Weinhold KJ. Lyerly HK, et al. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4601-5. doi: 10.1073/pnas.84.13.4601. Proc Natl Acad Sci U S A. 1987. PMID: 3037522 Free PMC article.

5

HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.

Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP. Weinhold KJ, et al. Among authors: lyerly hk. J Immunol. 1989 May 1;142(9):3091-7. J Immunol. 1989. PMID: 2468713

6

Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.

Weinhold KJ, Tyler DS, Lyerly HK. Weinhold KJ, et al. Among authors: lyerly hk. Dev Biol Stand. 1990;72:343-8. Dev Biol Stand. 1990. PMID: 2282991

7

Anti-HIV-1 ADCC.

Tyler DS, Lyerly HK, Weinhold KJ. Tyler DS, et al. Among authors: lyerly hk. AIDS Res Hum Retroviruses. 1989 Dec;5(6):557-63. doi: 10.1089/aid.1989.5.557. AIDS Res Hum Retroviruses. 1989. PMID: 2692657 Review. No abstract available.

8

Prospects for development of a vaccine against HTLV-III-related disorders.

Matthews TJ, Lyerly HK, Weinhold KJ, Langlois AJ, Rusche J, Putney SD, Gallo RC, Bolognesi DP. Matthews TJ, et al. Among authors: lyerly hk. AIDS Res Hum Retroviruses. 1987;3 Suppl 1:197-206. doi: 10.1089/aid.1987.3.197. AIDS Res Hum Retroviruses. 1987. PMID: 2825738 Review. No abstract available.

9

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

Lyerly HK, Reed DL, Matthews TJ, Langlois AJ, Ahearne PA, Petteway SR Jr, Weinhold KJ. Lyerly HK, et al. AIDS Res Hum Retroviruses. 1987;3(4):409-22. doi: 10.1089/aid.1987.3.409. AIDS Res Hum Retroviruses. 1987. PMID: 2833917

10

Cellular immune response to viral peptides in patients exposed to HIV.

Ahearne PM, Matthews TJ, Lyerly HK, White GC, Bolognesi DP, Weinhold KJ. Ahearne PM, et al. Among authors: lyerly hk. AIDS Res Hum Retroviruses. 1988 Aug;4(4):259-67. doi: 10.1089/aid.1988.4.259. AIDS Res Hum Retroviruses. 1988. PMID: 2462895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page